Our clients are typically marketing research firms or consulting agencies to augment their capabilities to include payer service offerings. Currently serving multiple US, EU and Asian marketing research organizations and consultancies. New product indication prioritization including sequencing of indications to best leverage access for treatments of rare/orphan diseases. How new hospital-based treatments/products can pass through and have better access vs. competition. This also includes gaining approval for products used in the hospital or at ambulatory surgery centers, infusion centers or…